Intellia Therapeutics Announces Second Quarter 2024 Financial Results and Highlights Recent Company Progress

Go back to Intellia Therapeutics Announces Second Quarter 2024 Financial Results and Highlights Recent Company Progress
(NASDAQ: NTLA) Delayed: 15.83 +0.16 (1.02%)
Previous Close $15.67    52 Week High $30.40 
Open $15.87    52 Week Low $11.86 
Day High $16.30    P/E N/A 
Day Low $15.57    EPS $0.00 
Volume 1,304,860